Blar i NTNU Open på forfatter "Baasland, Ingrid"
-
”CINDERELLA-study Cervical Intraepithelial Neoplasia - detecting relevant lesions - an evaluation of different links in the Norwegian cervical cancer screening program chain
Baasland, Ingrid (Doctoral theses at NTNU;2019:372, Doctoral thesis, 2019) -
Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population
Baasland, Ingrid (Journal article; Peer reviewed, 2019)Anyplex II HPV28 (`Anyplex`) is a semi-quantitative DNA PCR assay divided into set A, comprising 14 high risk (hr)HPV types; and set B, comprising 5 possibly hrHPV types and 9 low risk (lr)HPV types. We compared the ability ... -
Do they cope or mope? A survey of GPs’ experiences with the gradual renewal of the Norwegian Cervical Cancer Screening programme
Afseth, Sofie; Bowe, Anna (Master thesis, 2021)SAMMENDRAG Bakgrunn: Livmorhalsprogrammet er i dag i en endringsprosess, der HPV-test gradvis skal erstatte cytologi som primær screeningtest for kvinner i aldersgruppen 34-69 år. Fastleger har en essensiell rolle i ... -
Do they cope or mope? A survey of GPs’ experiences with the gradual renewal of the Norwegian Cervical Cancer Screening programme
Bowe, Anna; Afseth, Sofie (Master thesis, 2021)Bakgrunn Livmorhalsprogrammet er i dag i en endringsprosess, der HPV-test gradvis skal erstatte cytologi som primær screeningtest for kvinner i aldersgruppen 34-69 år. Fastleger har en essensiell rolle i Livmorhalsprogrammet. ... -
Do they cope or mope? A survey of GPs’ experiences with the changes in the Norwegian Cervical Cancer Screening Programme
Afseth, Sofie; Bowe, Anna; Mjølstad, Bente Prytz; Vie, Gunnhild Åberge; Baasland, Ingrid (Peer reviewed; Journal article, 2022)Objective To explore Norwegian general practitioners’ (GPs) experiences with the changes in the cervical cancer screening programme and to uncover which aspects of the programme they find most challenging. Design We ... -
HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
Aasbø, Gunvor; Trope, Ameli; Nygård, Mari; Christiansen, Irene Kraus; Baasland, Ingrid; Iversen, Grete Alræk; Munk, Ane Cecilie Dæhli; Christiansen, Marit Halonen; Presthus, Gro Kummeneje; Undem, Karina; Bjørge, Tone; Castle, Philip E.; Hansen, Bo Lars Thorvald Terning (Peer reviewed; Journal article, 2022)Background Cervical cancer screening participation is suboptimal in most settings. We assessed whether human papillomavirus (HPV) self-sampling may increase screening participation among long-term non-attenders in Norway. ... -
HPV-test som analysemetode i Livmorhalsprogrammet - Kvinners opplevelse ved positiv test
Høydalsvik, Rebecca (Master thesis, 2021)Introduksjon/Bakgrunn/Tidligere forskning: Globalt dør mer enn 250 000 kvinner av livmorhalskreft årlig. I Norge arbeider Livmorhalsprogrammet med tidlig oppdagelse og tiltak mot forstadier til livmorhalskreft. Helsedirektoratet ... -
Hvordan opplever HPV-vaksinerte kvinner livmorhalsscreening, når de for første gang inviteres til screeningprogrammet?
Hagen, Marthe (Master thesis, 2023)Introduksjon: Livmorhalskreft utgjør et folkehelseproblem, ettersom det i 2021 var 340 kvinner som fikk diagnosen og 79 kvinner som døde av sykdommen i Norge. Vesentlige faktorer for å forebygge krefttypen er humant ... -
Knowledge about and attitudes towards cervical cytology test among young women in Qingdao, China: A qualitative interview study
Li, Qiang (Master thesis, 2017)Background: Cervical cancer is the third most common cancer among women worldwide. It is one of the leading types of cancer in China. According to the Chinese National Health and Family Planning Commission, 130,000 new ...